Circulating IGFBP‐2: a novel biomarker for incident dementia

Circulating IGFBP‐2: a novel biomarker for incident dementia

Abstract Objective To determine the association between plasma insulin‐like growth factor binding protein 2 (IGFBP‐2) and cognitive outcomes. Methods We measured plasma IGFBP‐2 levels in 1596 (53% women, mean age 68.7 [SD 5.7] years) dementia‐free Framingham Offspring cohort participants between 199...

Full description

Bibliographic Details
Main Authors: Emer R. McGrath, Jayandra J. Himali, Daniel Levy, Sarah C. Conner, Charles S. DeCarli, Matthew P. Pase, Paul Courchesne, Claudia L. Satizabal, Ramachandran S. Vasan, Alexa S. Beiser, Sudha Seshadri
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.50854

Internet

https://doi.org/10.1002/acn3.50854

Similar Items